P2RY2 and breast cancer: Our previous results suggested that highly metastatic breast cancer cells MDA-MB-231 cells released high levels of ATP, and the subsequent activation of P2Y purinergic receptor 2 (P2Y2R) promoted invasion and tumor growth by inducing inflammasome activation [31].